EUVIMEDEUVIMED entdecken
Kohortenstudie

Real-World Effectiveness of Sequential Pneumococcal Vaccination in Older Adults: A Cohort Study

Yong Yi Tan, Reen Wan Li Ho, Jue Tao Lim, Calvin J Chiew iD, Soon Kok Lim, David Chien Boon Lye, Kelvin Bryan Tan, Liang En Wee iD

The Journal of Infectious Diseases · 16.06.2026 · 233 (6) · 1069-1080

DOI: 10.1093/infdis/jiag147 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 06.03.2026. Verfasst von Yong Yi Tan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore. Hauptthemen laut MEDLINE: Pneumococcal Infections, Pneumococcal Vaccines, Pneumonia, Pneumococcal, Vaccine Efficacy. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Ministry of Health, Government of Singapore, National Medical Research Council Office.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

While the real-world effectiveness of various pneumococcal vaccine formulations has been individually evaluated, comparative evaluations of 13-valent pneumococcal conjugate vaccine (PCV13)/23-valent pneumococcal polysaccharide vaccine (PPSV23) and combinations thereof are limited. We evaluated the real-world vaccine effectiveness of PCV13 alone, PPSV23 alone, or PCV13 followed by PPSV23 amongst older adults.

Methods

A population-based retrospective cohort study, including all adult Singaporeans aged ≥65 to 89 years from 1 January 2020 to 31 July 2024. The time to event from cohort enrollment to pneumococcal-related disease and all-cause pneumonia was measured, considering death as a competing risk. Cox regression models were used to estimate cause-specific hazards, with PCV13 alone, PPSV23 alone, and PCV13 followed by PPSV23 incorporated into models as time-dependent covariates. Vaccination status was assessed using the National Immunisation Registry; outcomes were identified using national healthcare claims data.

Results

A total of 656 337 older Singaporeans were included; 348 831 (53.1%) remained unvaccinated by the study end date. Sequential PCV13 followed by PPSV23 significantly protected against pneumococcal-related disease (adjusted hazard ratio, 0.22 [95% confidence interval, .06–.76]), pneumonia hospitalizations (0.94 [.91–.97]), and all-cause mortality (0.70 [.67–.74]). While PCV13 alone also reduced the risk of pneumonia hospitalization (adjusted hazard ratio, 0.96 [95% CI, .92–.99]) and all-cause mortality (0.86 [95% confidence interval, .83–.89]), vaccine effectiveness estimates were numerically lower than with sequential vaccination. For sequential vaccination, no significant waning of protection against all-cause pneumonia hospitalization or death was observed; a longer time interval (≥365 days) between PCV13 and PPSV23 was associated with a numerically lower risk of all-cause pneumonia hospitalization or death than a shorter interval (<365 days).

Conclusions

PCV13 followed by PPSV23 was associated with lower risk of pneumococcal-related disease, pneumonia, and all-cause mortality, supporting recommendations for sequential vaccination in older adults.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pneumococcal InfectionsPneumococcal VaccinesPneumonia, PneumococcalVaccine EfficacyAgedAged, 80 and overFemaleHumansMaleRetrospective StudiesSingaporeStreptococcus pneumoniaeVaccination Coverage

Stichwörter der Autor:innen

Pneumococcal diseaseolder adultspneumoniavaccinationvaccine effectiveness

Substanzen

13-valent pneumococcal vaccine23-valent pneumococcal capsular polysaccharide vaccinePneumococcal Vaccines

Autor:innen und Institutionen

  • Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
  • National Centre for Infectious Diseases, Singapore.
  • Communicable Diseases Agency, Singapore.
  • Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore.
  • Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Duke-NUS Graduate Medical School, National University of Singapore, Singapore.

ORCID-Profile: Calvin J Chiew, Liang En Wee

Förderung

  • Ministry of Health
  • Government of Singapore
  • National Medical Research Council Office
  • MOH Holdings
  • National Epidemic Preparedness and Response R&D Programme
  • National Medical Research Council
  • Singhealth

Zitieren

APA

Tan, Y. Y., Ho, R. W. L., Lim, J. T., Chiew, C. J., Lim, S. K., Lye, D. C. B., Tan, K. B., & Wee, L. E. (2026). Real-World Effectiveness of Sequential Pneumococcal Vaccination in Older Adults: A Cohort Study. The Journal of Infectious Diseases, 233(6), 1069-1080. https://doi.org/10.1093/infdis/jiag147

Vancouver

Tan YY, Ho RWL, Lim JT, Chiew CJ, Lim SK, Lye DCB, et al. Real-World Effectiveness of Sequential Pneumococcal Vaccination in Older Adults: A Cohort Study. The Journal of Infectious Diseases. 2026;233(6):1069-1080. doi:10.1093/infdis/jiag147

BibTeX
@article{Tan2026,
  author = {Tan, Yong Yi and Ho, Reen Wan Li and Lim, Jue Tao and Chiew, Calvin J and Lim, Soon Kok and Lye, David Chien Boon and Tan, Kelvin Bryan and Wee, Liang En},
  title = {Real-World Effectiveness of Sequential Pneumococcal Vaccination in Older Adults: A Cohort Study},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  volume = {233},
  number = {6},
  pages = {1069--1080},
  doi = {10.1093/infdis/jiag147}
}
Kostenlos starten →